EC Number | Application | Comment | Organism |
---|---|---|---|
3.4.16.4 | medicine | VanX, being a required enzyme for bacterial antibiotic resistance, should be a key target in circumventing clinical vancomycin resistance | Escherichia coli |
EC Number | Cloned (Comment) | Organism |
---|---|---|
3.4.13.22 | expressed as a maltose-binding protein fusion protein in Escherichia coli | Enterococcus faecium |
3.4.16.4 | into the pMAL-c2X vector for expression in Escherichia coli JM109 cells | Escherichia coli |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.13.22 | D-Ala-PSI[P(OOH)O]-D-Ala | - |
Enterococcus faecium | |
3.4.13.22 | D-Ala-PSI[P(OOH)O]-D-Phe | - |
Enterococcus faecium | |
3.4.16.4 | D-Ala(P,O)D-Ala | acts as slow binding inhibitor | Escherichia coli | |
3.4.16.4 | D-Ala(P,O)D-Phe | acts as slow binding inhibitor | Escherichia coli |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
3.4.16.4 | cell wall | - |
Escherichia coli | 5618 | - |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
3.4.16.4 | Zn2+ | - |
Escherichia coli |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
3.4.16.4 | 24000 | - |
determined by SDS-PAGE | Escherichia coli |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.16.4 | D-Ala-D-Ala + H2O | Escherichia coli | - |
D-Ala + D-Ala | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.13.22 | Enterococcus faecium | - |
- |
- |
3.4.16.4 | Escherichia coli | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.4.13.22 | by an amylose affinity column and further separation by the DEAE ion exchange chromatography | Enterococcus faecium |
3.4.16.4 | using an amylose affinity column, the MBP-tag is removed by factor Xa cleavage | Escherichia coli |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.16.4 | D-Ala-D-Ala + H2O | - |
Escherichia coli | D-Ala + D-Ala | - |
? | |
3.4.16.4 | D-Ala-D-Phe + H2O | - |
Escherichia coli | D-Ala + D-Phe | - |
? | |
3.4.16.4 | D-Ala-D-Trp + H2O | - |
Escherichia coli | D-Ala + D-Trp | - |
? | |
3.4.16.4 | D-Ala-D-Tyr + H2O | - |
Escherichia coli | D-Ala + D-Tyr | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.13.22 | VanX | - |
Enterococcus faecium |
3.4.16.4 | D,D-dipeptidase | - |
Escherichia coli |
3.4.16.4 | serine-type D-Ala-D-Ala carboxypeptidase | - |
Escherichia coli |
3.4.16.4 | VanX | - |
Escherichia coli |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.4.13.22 | 0.00196 | - |
D-Ala-PSI[P(OOH)O]-D-Phe | koff: 0.00231 sec-1, results reveals that both dipeptide phosphonates are slow-binding inhibitors of VanX. Moreover, in comparison with D-Ala(P,O)D-Ala phosphonate dipeptide, an additional aromatic interaction with the Phe79 residue in the active site of the enzyme may account for its higher affinity to VanX | Enterococcus faecium | |
3.4.13.22 | 0.0165 | - |
D-Ala-PSI[P(OOH)O]-D-Ala | koff: 0.0180 sec-1, results reveals that both dipeptide phosphonates are slow-binding inhibitors of VanX | Enterococcus faecium |